Dr. Martens posted a 46 percent rise in interim profits, driven by a recovery in store sales as they reopened after Covid lockdowns, but the company warned that shipping delays in its U.S. business would continue into the next fiscal year.
Your membership benefits:
If you aren’t ready to subscribe now, choose the 30 day trial for 1€. To continue reading this article REGISTER NOW.